What is the current valuation of the dental anesthesia market in Japan as of 2024?

The market valuation was $75.85 Million in 2024. Read More

What is the projected market size for dental anesthesia in Japan by 2035?

The projected valuation for 2035 is $121.12 Million. Read More

What is the expected CAGR for the dental anesthesia market in Japan from 2025 to 2035?

The expected CAGR during the forecast period 2025 - 2035 is 4.35%. Read More

Which product type generated the highest revenue in the dental anesthesia market in 2024?

Lidocaine generated the highest revenue, with a valuation between $30.0 Million and $48.0 Million. Read More

What are the revenue ranges for the different modes of administration in the dental anesthesia market?

Maxillary anesthesia ranged from $30.34 Million to $49.0 Million, while Mandibular ranged from $25.17 Million to $40.0 Million. Read More

Which technique accounted for the most revenue in the dental anesthesia market in 2024?

Local Infiltration accounted for the most revenue, with a range of $30.0 Million to $48.0 Million. Read More

What is the revenue range for the duration of action segment in the dental anesthesia market?

The revenue range for the duration of action segment is $15.0 Million to $24.0 Million for short duration, and $30.85 Million to $49.12 Million for long duration. Read More

Which end user segment had the highest revenue in the dental anesthesia market in 2024?

Clinics had the highest revenue, with a range of $35.0 Million to $55.0 Million. Read More

What distribution channels are expected to perform well in the dental anesthesia market?

Pharmacies and Drug Stores generated revenue between $30.0 Million and $48.0 Million, indicating strong performance. Read More

Who are the key players in the Japan dental anesthesia market?

Key players include Dentsply Sirona, Henry Schein, Patterson Companies, and Septodont, among others. Read More

Japan Dental Anesthesia Market

ID: MRFR/HC/42989-HCR

200 Pages

Rahul Gotadki

Last Updated: April 06, 2026

Japan Dental Anesthesia Market Research Report By Product Type (lidocaine, mepivacaine, prilocaine, bupivacaine 0.5% with epinephrine1:200,000, articaine, others), By Mode of Administration (maxillary, mandibular, others), By Technique (local infiltration, field block, nerve block), By Duration of Action (short, medium, long), By End User (hospital clinics, clinics, other), By Distribution Channel (pharmacies and drug stores, e-commerce, other) and By Intended Audience (hospitals, dental clinics, research institutes, dental software manufacturers, healthcare it companies) - Growth & Industry Forecast 2025 To 2035

Japan Dental Anesthesia Market Infographic

Summary Table of Contents Segmentation Download PDF

Certified Researchers

Customize Report

1 SECTION I: EXECUTIVE SUMMARY AND KEY HIGHLIGHTS
1. 1.1 EXECUTIVE SUMMARY
  1. 1.1.1 Market Overview
  2. 1.1.2 Key Findings
  3. 1.1.3 Market Segmentation
  4. 1.1.4 Competitive Landscape
  5. 1.1.5 Challenges and Opportunities
  6. 1.1.6 Future Outlook
2 SECTION II: SCOPING, METHODOLOGY AND MARKET STRUCTURE
1. 2.1 MARKET INTRODUCTION
  1. 2.1.1 Definition
  2. 2.1.2 Scope of the study
    1. 2.1.2.1 Research Objective
    2. 2.1.2.2 Assumption
    3. 2.1.2.3 Limitations
2. 2.2 RESEARCH METHODOLOGY
  1. 2.2.1 Overview
  2. 2.2.2 Data Mining
  3. 2.2.3 Secondary Research
  4. 2.2.4 Primary Research
    1. 2.2.4.1 Primary Interviews and Information Gathering Process
    2. 2.2.4.2 Breakdown of Primary Respondents
  5. 2.2.5 Forecasting Model
  6. 2.2.6 Market Size Estimation
    1. 2.2.6.1 Bottom-Up Approach
    2. 2.2.6.2 Top-Down Approach
  7. 2.2.7 Data Triangulation
  8. 2.2.8 Validation
3 SECTION III: QUALITATIVE ANALYSIS
1. 3.1 MARKET DYNAMICS
  1. 3.1.1 Overview
  2. 3.1.2 Drivers
  3. 3.1.3 Restraints
  4. 3.1.4 Opportunities
2. 3.2 MARKET FACTOR ANALYSIS
  1. 3.2.1 Value chain Analysis
  2. 3.2.2 Porter's Five Forces Analysis
    1. 3.2.2.1 Bargaining Power of Suppliers
    2. 3.2.2.2 Bargaining Power of Buyers
    3. 3.2.2.3 Threat of New Entrants
    4. 3.2.2.4 Threat of Substitutes
    5. 3.2.2.5 Intensity of Rivalry
  3. 3.2.3 COVID-19 Impact Analysis
    1. 3.2.3.1 Market Impact Analysis
    2. 3.2.3.2 Regional Impact
    3. 3.2.3.3 Opportunity and Threat Analysis
4 SECTION IV: QUANTITATIVE ANALYSIS
1. 4.1 Chemicals and Materials, BY Product Type (USD Million)
  1. 4.1.1 Lidocaine
  2. 4.1.2 Mepivacaine
  3. 4.1.3 Prilocaine
  4. 4.1.4 Bupivacaine 0.5% with epinephrine 1:200,000
  5. 4.1.5 Articaine
  6. 4.1.6 Others
2. 4.2 Chemicals and Materials, BY Mode of Administration (USD Million)
  1. 4.2.1 Maxillary
  2. 4.2.2 Mandibular
  3. 4.2.3 Others
3. 4.3 Chemicals and Materials, BY Technique (USD Million)
  1. 4.3.1 Local Infiltration
  2. 4.3.2 Field Block
  3. 4.3.3 Nerve Block
4. 4.4 Chemicals and Materials, BY Duration of Action (USD Million)
  1. 4.4.1 Short
  2. 4.4.2 Medium
  3. 4.4.3 Long
5. 4.5 Chemicals and Materials, BY End User (USD Million)
  1. 4.5.1 Hospital Clinics
  2. 4.5.2 Clinics
  3. 4.5.3 Other
6. 4.6 Chemicals and Materials, BY Distribution Channel (USD Million)
  1. 4.6.1 Pharmacies And Drug Stores
  2. 4.6.2 E-Commerce
  3. 4.6.3 Other
5 SECTION V: COMPETITIVE ANALYSIS
1. 5.1 Competitive Landscape
  1. 5.1.1 Overview
  2. 5.1.2 Competitive Analysis
  3. 5.1.3 Market share Analysis
  4. 5.1.4 Major Growth Strategy in the Chemicals and Materials
  5. 5.1.5 Competitive Benchmarking
  6. 5.1.6 Leading Players in Terms of Number of Developments in the Chemicals and Materials
  7. 5.1.7 Key developments and growth strategies
    1. 5.1.7.1 New Product Launch/Service Deployment
    2. 5.1.7.2 Merger & Acquisitions
    3. 5.1.7.3 Joint Ventures
  8. 5.1.8 Major Players Financial Matrix
    1. 5.1.8.1 Sales and Operating Income
    2. 5.1.8.2 Major Players R&D Expenditure. 2023
2. 5.2 Company Profiles
  1. 5.2.1 Dentsply Sirona (US)
    1. 5.2.1.1 Financial Overview
    2. 5.2.1.2 Products Offered
    3. 5.2.1.3 Key Developments
    4. 5.2.1.4 SWOT Analysis
    5. 5.2.1.5 Key Strategies
  2. 5.2.2 Henry Schein (US)
    1. 5.2.2.1 Financial Overview
    2. 5.2.2.2 Products Offered
    3. 5.2.2.3 Key Developments
    4. 5.2.2.4 SWOT Analysis
    5. 5.2.2.5 Key Strategies
  3. 5.2.3 Patterson Companies (US)
    1. 5.2.3.1 Financial Overview
    2. 5.2.3.2 Products Offered
    3. 5.2.3.3 Key Developments
    4. 5.2.3.4 SWOT Analysis
    5. 5.2.3.5 Key Strategies
  4. 5.2.4 Septodont (FR)
    1. 5.2.4.1 Financial Overview
    2. 5.2.4.2 Products Offered
    3. 5.2.4.3 Key Developments
    4. 5.2.4.4 SWOT Analysis
    5. 5.2.4.5 Key Strategies
  5. 5.2.5 Heraeus Kulzer (DE)
    1. 5.2.5.1 Financial Overview
    2. 5.2.5.2 Products Offered
    3. 5.2.5.3 Key Developments
    4. 5.2.5.4 SWOT Analysis
    5. 5.2.5.5 Key Strategies
  6. 5.2.6 3M (US)
    1. 5.2.6.1 Financial Overview
    2. 5.2.6.2 Products Offered
    3. 5.2.6.3 Key Developments
    4. 5.2.6.4 SWOT Analysis
    5. 5.2.6.5 Key Strategies
  7. 5.2.7 B. Braun (DE)
    1. 5.2.7.1 Financial Overview
    2. 5.2.7.2 Products Offered
    3. 5.2.7.3 Key Developments
    4. 5.2.7.4 SWOT Analysis
    5. 5.2.7.5 Key Strategies
  8. 5.2.8 Kavo Kerr (US)
    1. 5.2.8.1 Financial Overview
    2. 5.2.8.2 Products Offered
    3. 5.2.8.3 Key Developments
    4. 5.2.8.4 SWOT Analysis
    5. 5.2.8.5 Key Strategies
  9. 5.2.9 Dental Wings (CA)
    1. 5.2.9.1 Financial Overview
    2. 5.2.9.2 Products Offered
    3. 5.2.9.3 Key Developments
    4. 5.2.9.4 SWOT Analysis
    5. 5.2.9.5 Key Strategies
3. 5.3 Appendix
  1. 5.3.1 References
  2. 5.3.2 Related Reports
6 LIST OF FIGURES
1. 6.1 MARKET SYNOPSIS
2. 6.2 JAPAN MARKET ANALYSIS BY PRODUCT TYPE
3. 6.3 JAPAN MARKET ANALYSIS BY MODE OF ADMINISTRATION
4. 6.4 JAPAN MARKET ANALYSIS BY TECHNIQUE
5. 6.5 JAPAN MARKET ANALYSIS BY DURATION OF ACTION
6. 6.6 JAPAN MARKET ANALYSIS BY END USER
7. 6.7 JAPAN MARKET ANALYSIS BY DISTRIBUTION CHANNEL
8. 6.8 KEY BUYING CRITERIA OF CHEMICALS AND MATERIALS
9. 6.9 RESEARCH PROCESS OF MRFR
10. 6.10 DRO ANALYSIS OF CHEMICALS AND MATERIALS
11. 6.11 DRIVERS IMPACT ANALYSIS: CHEMICALS AND MATERIALS
12. 6.12 RESTRAINTS IMPACT ANALYSIS: CHEMICALS AND MATERIALS
13. 6.13 SUPPLY / VALUE CHAIN: CHEMICALS AND MATERIALS
14. 6.14 CHEMICALS AND MATERIALS, BY PRODUCT TYPE, 2024 (% SHARE)
15. 6.15 CHEMICALS AND MATERIALS, BY PRODUCT TYPE, 2024 TO 2035 (USD Million)
16. 6.16 CHEMICALS AND MATERIALS, BY MODE OF ADMINISTRATION, 2024 (% SHARE)
17. 6.17 CHEMICALS AND MATERIALS, BY MODE OF ADMINISTRATION, 2024 TO 2035 (USD Million)
18. 6.18 CHEMICALS AND MATERIALS, BY TECHNIQUE, 2024 (% SHARE)
19. 6.19 CHEMICALS AND MATERIALS, BY TECHNIQUE, 2024 TO 2035 (USD Million)
20. 6.20 CHEMICALS AND MATERIALS, BY DURATION OF ACTION, 2024 (% SHARE)
21. 6.21 CHEMICALS AND MATERIALS, BY DURATION OF ACTION, 2024 TO 2035 (USD Million)
22. 6.22 CHEMICALS AND MATERIALS, BY END USER, 2024 (% SHARE)
23. 6.23 CHEMICALS AND MATERIALS, BY END USER, 2024 TO 2035 (USD Million)
24. 6.24 CHEMICALS AND MATERIALS, BY DISTRIBUTION CHANNEL, 2024 (% SHARE)
25. 6.25 CHEMICALS AND MATERIALS, BY DISTRIBUTION CHANNEL, 2024 TO 2035 (USD Million)
26. 6.26 BENCHMARKING OF MAJOR COMPETITORS
7 LIST OF TABLES
1. 7.1 LIST OF ASSUMPTIONS
7.1.1
1. 7.2 Japan MARKET SIZE ESTIMATES; FORECAST
  1. 7.2.1 BY PRODUCT TYPE, 2025-2035 (USD Million)
  2. 7.2.2 BY MODE OF ADMINISTRATION, 2025-2035 (USD Million)
  3. 7.2.3 BY TECHNIQUE, 2025-2035 (USD Million)
  4. 7.2.4 BY DURATION OF ACTION, 2025-2035 (USD Million)
  5. 7.2.5 BY END USER, 2025-2035 (USD Million)
  6. 7.2.6 BY DISTRIBUTION CHANNEL, 2025-2035 (USD Million)
2. 7.3 PRODUCT LAUNCH/PRODUCT DEVELOPMENT/APPROVAL
7.3.1
1. 7.4 ACQUISITION/PARTNERSHIP
7.4.1

Certified Researchers

Customize Report

Japan Chemicals and Materials Market Segmentation

Chemicals and Materials By Product Type (USD Million, 2025-2035)

Lidocaine
Mepivacaine
Prilocaine
Bupivacaine 0.5% with epinephrine 1:200,000
Articaine
Others

Chemicals and Materials By Mode of Administration (USD Million, 2025-2035)

Maxillary
Mandibular
Others

Chemicals and Materials By Technique (USD Million, 2025-2035)

Local Infiltration
Field Block
Nerve Block

Chemicals and Materials By Duration of Action (USD Million, 2025-2035)

Short
Medium
Long

Chemicals and Materials By End User (USD Million, 2025-2035)

Hospital Clinics
Clinics
Other

Chemicals and Materials By Distribution Channel (USD Million, 2025-2035)

Pharmacies And Drug Stores
E-Commerce
Other

Customer Stories

“This is really good guys. Excellent work on a tight deadline. I will continue to use you going forward and recommend you to others. Nice job”

Noah Malgeri Co-Founder

“Thanks. It’s been a pleasure working with you, please use me as reference with any other Intel employees.”

Joseph Aguayo Sales Operations & Pricing Manager

“Thanks for sending the report it gives us a good global view of the Betaïne market.”

Peter Groot koerkamp Account and Business Manager

“Thank you, this will be very helpful for OQS.”

La Terria Dodd Program Support Specialist

“We found the report very insightful! we found your research firm very helpful. I'm sending this email to secure our future business.”

Younghwan Choi Senior Retail Manager

“I am very pleased with how market segments have been defined in a relevant way for my purposes (such as "Portable Freezers & refrigerators" and "last-mile"). In general the report is well structured. Thanks very much for your efforts.”

Mark Irwin Management Consultant

“I have been reading the first document or the study, ,the Global HVAC and FP market report 2021 till 2026. Must say, good info! I have not gone in depth at all parts, but got a good indication of the data inside!”